These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7166179)

  • 1. Human metabolism of tolfenamic acid. II. Structure of metabolites and C-13 NMR assignments of fenamates.
    Khalifah RG; Hignite CE; Pentikäinen PJ; Penttilä A; Neuvonen PJ
    Eur J Drug Metab Pharmacokinet; 1982; 7(4):269-76. PubMed ID: 7166179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raman and IR spectroscopic studies of fenamates--conformational differences in polymorphs of flufenamic acid, mefenamic acid and tolfenamic acid.
    Jabeen S; Dines TJ; Leharne SA; Chowdhry BZ
    Spectrochim Acta A Mol Biomol Spectrosc; 2012 Oct; 96():972-85. PubMed ID: 22954807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter: Circular dichroism study on inclusion complexes of beta-cyclodextrin with anti-inflammatory fanamates.
    Ikeda K; Uekama K; Otagiri M; Hatano M
    J Pharm Sci; 1974 Jul; 63(7):1168-9. PubMed ID: 4852725
    [No Abstract]   [Full Text] [Related]  

  • 4. Fenamates and the potent inhibition of human liver phenol sulphotransferase.
    Vietri M; De Santi C; Pietrabissa A; Mosca F; Pacifici GM
    Xenobiotica; 2000 Feb; 30(2):111-6. PubMed ID: 10718119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral antipyretic therapy: evaluation of the N-aryl-anthranilic acid derivatives mefenamic acid, tolfenamic acid and flufenamic acid.
    Keinänen S; Similä S; Kouvalainen K
    Eur J Clin Pharmacol; 1978 Jul; 13(5):331-44. PubMed ID: 668793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of non-steroidal anti-inflammatory drugs on polymorphonuclear leukocyte functions in vitro: focus on fenamates.
    Kankaanranta H; Moilanen E; Vapaatalo H
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Dec; 350(6):685-91. PubMed ID: 7708126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capillary isotachophoretic determination of flufenamic, mefenamic, niflumic and tolfenamic acid in pharmaceuticals.
    Polásek M; Pospísilová M; Urbánek M
    J Pharm Biomed Anal; 2000 Aug; 23(1):135-42. PubMed ID: 10898163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of magnesium hydroxide on the absorption of tolfenamic and mefenamic acids.
    Neuvonen PJ; Kivistö KT
    Eur J Clin Pharmacol; 1988; 35(5):495-501. PubMed ID: 3266151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flufenamic and tolfenamic acids inhibit calcium influx in human polymorphonuclear leukocytes.
    Kankaanranta H; Moilanen E
    Mol Pharmacol; 1995 May; 47(5):1006-13. PubMed ID: 7746266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenamates inhibit human sodium channel Nav1.7 and Nav1.8.
    Sun JF; Xu YJ; Kong XH; Su Y; Wang ZY
    Neurosci Lett; 2019 Mar; 696():67-73. PubMed ID: 30528877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolfenamic acid. Detection and structure of urinary metabolites.
    Pedersen SB; Alhede B; Buchardt O; Møller J; Bock K
    Arzneimittelforschung; 1981; 31(11):1944-8. PubMed ID: 7198475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and 1H NMR spectroscopic characterization of phase II metabolites of tolfenamic acid.
    Sidelmann UG; Christiansen E; Krogh L; Cornett C; Tjørnelund J; Hansen SH
    Drug Metab Dispos; 1997 Jun; 25(6):725-31. PubMed ID: 9193874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human metabolism of tolfenamic acid. I. Isolation, preliminary characterization and pharmacokinetics of tolfenamic acid and its metabolites.
    Pentikäinen PJ; Penttilä A; Neuvonen PJ; Khalifah RG; Hignite CE
    Eur J Drug Metab Pharmacokinet; 1982; 7(4):259-67. PubMed ID: 7166178
    [No Abstract]   [Full Text] [Related]  

  • 14. Simultaneous determination of mefenamic and tolfenamic acids in real samples by terbium-sensitized luminescence.
    Pulgarín JA; Molina AA; Ferreras FM
    J Fluoresc; 2012 Nov; 22(6):1483-92. PubMed ID: 22752433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-induced difference spectrophotometric methods for drug analysis. Part 2: Determination of mefenamic and flufenamic acid.
    Hassan SM; Shaaban SA
    Pharmazie; 1984 Oct; 39(10):691-3. PubMed ID: 6522446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of engineered cytochrome P450 mutants as biocatalysts for the synthesis of benzylic and aromatic metabolites of fenamic acid NSAIDs.
    Venkataraman H; Verkade-Vreeker MC; Capoferri L; Geerke DP; Vermeulen NP; Commandeur JN
    Bioorg Med Chem; 2014 Oct; 22(20):5613-20. PubMed ID: 24999003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrophotometric method for the determination of flufenamic and mefenamic acids.
    Aboul Khier A; el-Sadek M; Baraka M
    Analyst; 1987 Oct; 112(10):1399-403. PubMed ID: 3434820
    [No Abstract]   [Full Text] [Related]  

  • 18. Conformational State of Fenamates at the Membrane Interface: A MAS NOESY Study.
    Khodov IA; Belov KV; Huster D; Scheidt HA
    Membranes (Basel); 2023 Jun; 13(6):. PubMed ID: 37367811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a tolfenamic acid metabolite in the horse by gas chromatography-mass spectrometry.
    Jaussaud P; Guieu D; Courtot D; Barbier B; Bonnaire Y
    J Chromatogr; 1992 Jan; 573(1):136-40. PubMed ID: 1564092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrofluorimetric determination of anthranilic acid derivatives based on terbium sensitized fluorescence.
    Ioannou PC; Rusakova NV; Andrikopoulou DA; Glynou KM; Tzompanaki GM
    Analyst; 1998 Dec; 123(12):2839-43. PubMed ID: 10435348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.